EGFR and lung cancer: Although phenotype characteristics of EGFR-TKI-resistant lung cancer cells can be classified as EGFR-dependent and EGFR-independent growth [26], deciding an appropriate treatment strategy is difficult due to the acquired resistance being driven by heterogeneous mechanisms.